All News
Filter News
Found 808,679 articles
-
Kodiak Sciences to Present at Upcoming Conferences - Mar 02, 2021
3/2/2021
Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that management will present at the following upcoming virtual investor conferences
-
Greenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring Conferences
3/2/2021
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, announced that Snehal Patel, CEO of Greenwich LifeSciences, will participate in multiple virtual investor conferences in March 2021.
-
Beyond Batten Disease Foundation Announces Agreement with Actelion Pharmaceuticals Ltd to Provide Drug Product for BBDF-101
3/2/2021
Beyond Batten Disease Foundation is pleased to announce an agreement with Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, to provide Zavesca® for the development of BBDF-101, a proprietary combination of miglustat and trehalose to treat juvenile Batten disease.
-
Pacific Biosciences Grants Equity Incentive Award to New Employee - Mar 02, 2021
3/2/2021
Pacific Biosciences of California, Inc. announced that the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock and restricted stock units covering 40,000 shares of Pacific Biosciences common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan effective on February 25, 2021.
-
Owens & Minor Announces Launch of Senior Notes Offering - Mar 02, 2021
3/2/2021
Owens & Minor, Inc. announced that it has launched a private offering of $500 million aggregate principal amount of senior notes due 2029, subject to customary and market conditions.
-
Chicago’s Associated Urological Specialists Joins Solaris Health as Momentum Builds for National Urology Platform
3/2/2021
Solaris Health Holdings, LLC is pleased to announce that Chicago-based Associated Urological Specialists has joined as an affiliated practice.
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 02, 2021
3/2/2021
Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted five newly-hired employees options to purchase an aggregate of 44,000 shares of Akebia's common stock on February 26, 2021, as inducements material to each such employee's entering into employment with Akebia.
-
GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference - Mar 02, 2021
3/2/2021
Global Blood Therapeutics, Inc. will participate at the H.C. Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021. A presentation by Ted W. Love, M.D., president and CEO of GBT, will be available at 7:00 a.m. ET.
-
Chinook Therapeutics to Present at Upcoming Investor Conferences - Mar 02, 2021
3/2/2021
Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced that Chinook management is scheduled to participate in fireside chats at the following upcoming virtual investor conferences
-
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody
3/2/2021
Recently, CMAB Biopharma Inc's partner QureBio Ltd has announced its innovative drug Q-1802 received United States Food and Drug Administration clearance for an Investigational New Drug application.
-
AVEO Oncology to Present at the H.C. Wainwright Global Life Sciences Conference - Mar 02, 2021
3/2/2021
AVEO Oncology announced that Michael Bailey, president and chief executive officer of AVEO, will present at the H.C. Wainwright Global Life Sciences Conference, being held virtually on March 9-10, 2021.
-
World Hearing Day – Amplifon Confirms Commitment to Ongoing Prevention & Treatment of Hearing Loss
3/2/2021
Amplifon is proud to celebrate World Hearing Day, confirming its commitment to the treatment and prevention of hearing loss, a condition that impacts nearly 40 million Americans.
-
Varian Announces CEO Succession Plan
3/2/2021
Varian announced that Chief Executive Officer Dow Wilson, after more than 16 years with the Company, will retire upon the successful completion of the proposed combination of Varian and Siemens Healthineers AG.
-
Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results
3/2/2021
Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, reported financial results for the fourth quarter and full year ended December 31, 2020.
-
NAMSA Acquires American Preclinical Services (APS), Becoming the Preeminent CRO Leader in Interventional and Surgical Preclinical Research Solutions
3/2/2021
NAMSA®, the world’s only 100% medical device-focused Contract Research Organization providing full continuum development solutions, announced its acquisition of Minneapolis-based American Preclinical Services, a full service preclinical CRO.
-
Deep Immune Profiling Shows Significant Immune Activation in Children with MIS-C
3/2/2021
CHOP/Penn study shows T cell activation in children with MIS-C more similar to adults with severe COVID-19
-
Results Published in Study Show MolecuLight Fluorescence Point-of-Care Imaging Detected Pseudomonas Aeruginosa (PA) in Wounds with a PPV of 93%
3/2/2021
Study Reveals the Utility of Cyan Fluorescence to Reliably Predict Pseudomonas, a Bacterial Pathogen that Precludes Wound Healing and Often Evades Conventional Treatment Methods
-
Theravance Biopharma to Participate in an Upcoming Investor Conference - Mar 02, 2021
3/2/2021
Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will participate in a pre-recorded Fireside Chat at the H.C.
-
Lisa Deschamps Joins Verona Pharma as Non-Executive Director
3/2/2021
Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces, effective March 1, 2021, Ms. Lisa Deschamps has joined the board as a Non-Executive Director.
-
iCAD Announces Proposed Public Offering of Common Stock - Mar 02, 2021
3/2/2021
iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.